As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/2/24  Young Jonathan                    4          Officer²    1:7K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
  4/3/24  Young Jonathan                    4          Officer²    1:8K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
  4/1/24  Young Jonathan                    144                    1:4K   Akero Therapeutics, Inc.          J.P. Morgan Secs LLC/FA  
 3/15/24  Young Jonathan                    4          Officer²    1:6K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
  3/5/24  Young Jonathan                    4          Officer²    1:7K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
12/29/23  Young Jonathan                    4          Officer²    1:9K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
12/29/23  Young Jonathan                    144                    1:9K   Akero Therapeutics, Inc.          E TRADE Fin’l… Office/FA 
12/18/23  Young Jonathan                    4          Officer²    1:6K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
12/12/23  Young Jonathan                    4          Officer²    1:8K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
11/21/23  Young Jonathan                    4          Officer²    1:6K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
 10/4/23  Young Jonathan                    4          Officer²    1:8K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
 10/2/23  Young Jonathan                    144                    1:4K   Akero Therapeutics, Inc.          J.P. Morgan Secs LLC/FA  
 9/25/23  Young Jonathan                    4          Officer²    1:6K   Akero Therapeutics, Inc.          Donnelley … Solutions/FA 
 6/15/23  Young Jonathan                    4          Officer²    1:6K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
 3/14/23  Young Jonathan                    4          Officer²    1:6K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
  1/5/23  Young Jonathan                    4          Officer²    1:9K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
12/28/22  Young Jonathan                    4          Officer²    1:12K  Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
12/20/22  Young Jonathan                    4          Officer²    1:5K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
12/13/22  Young Jonathan                    4          Officer²    1:8K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 
10/27/22  Young Jonathan                    4          Officer²    1:9K   Akero Therapeutics, Inc.          Donnelley Fin’l S… 06/FA 

____________
¹	Filing/Form Types:  -A
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.